Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · 6-K

Telix Pharmaceuticals Ltd

TLPPFOTCEQUITYCurrent

SEC Filing

Filed Jul 21, 2026Accepted Jul 21, 2026, 7:06 AM EDTCIK 2007191Accession 0001628280-26-048922
Share

Company context

Current securities

Recent company filings

  1. 6-K filingSep 21, 2026
  2. 6-K filingSep 14, 2026
  3. 6-K filingSep 2, 2026
  4. 6-K filingSep 1, 2026
  5. 6-K filingAug 20, 2026

As-filed source

Primary evidence